- Home
- Business & Economics
- Personal Finance
- Biotech Investing (Every Investor's Guide)
Biotech Investing (Every Investor's Guide)
List Price:
$32.00
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
James D. Mccamant
Format:
Hardcover
Pages:
208
Publisher:
Basic Books (June 6, 2002)
Language:
English
ISBN-13:
9780738205090
ISBN-10:
0738205095
Case Pack:
32
File:
hbgusa-hbgusa_onix30_P8654520_05262025-20250526.xml
Folder:
hbgusa
As low as:
$24.64
List Price:
$32.00
Publisher Identifier:
P-HACH
Discount Code:
A
Weight:
11.2oz
Dimensions:
6" x 9"
Audience:
General/trade
Country of Origin:
United States
Pub Discount:
65
Imprint:
Basic Books
Overview
Biotechnology is indisputably one of the fastest-growing and most promising industries. Virtually immune to swings in the economic cycles, biotech stocks continue to perform steadily as high-tech stocks lose their steam.In Biotech Investing, Jim McCamant offers proven strategies and savvy advice on how to capitalize on the unprecedented opportunities in this high-potential sector. Written by a recognized authority, this book dissects biotech business models from start-up to IPO and discusses in detail the most important factors that affect biotech research. Comprehensive in scope, it looks at the best and worst biotech contenders, discusses all the most newsworthy developments in the field, and shows how they translate into business success or failure. It outlines simple criteria for choosing the best biotech stocks and for understanding the sometimes complicated dynamics of this sector.
